Pros | 5Y returns in the top 25% of the category. Lower expense ratio. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 9 Months | 13 Years 3 Months | ||
Fund AUM | ₹2640 Cr | ₹7875 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.48% | 0.92% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 35 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.75% | 98.97% | ||
Debt % | - | - | ||
P/E | 38.73 | 34.75 | ||
P/B | 5.16 | 5.37 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.83% | 1.18% | ||
3-Month Return | -1.78% | -2.27% | ||
6-Month Return | -1.6% | -2.12% | ||
1-Year Return | 10.08% | 9.95% | ||
3-Year Return | 24.03% | 23.59% | ||
5-Year Return | 16.41% | 15.65% |
Sharpe | 0.92 | 0.97 | ||
Alpha | -0.59 | 0.33 | ||
Beta | 0.98 | 0.9 | ||
Standard Deviation | 16.5 | 15.32 | ||
Information Ratio | -0.34 | -0.32 |
Description | Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera, Tanmay Mehta | Sailesh Raj Bhan, Divya Sharma, Lokesh Maru, Kinjal Desai |